Used in pharmaceutical synthesis as a key intermediate for active pharmaceutical ingredients (APIs), particularly in the development of angiotensin II receptor antagonists for hypertension treatment. Its tetrazole moiety mimics carboxylic acid groups, enhancing metabolic stability and bioavailability in drug candidates. Also employed in research for designing novel compounds with improved binding affinity to target receptors.